Publikationen, an denen er mitarbeitet Juan Carlos Leza Cerro (19)

2024

  1. N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia

    Translational Psychiatry, Vol. 14, Núm. 1

  2. THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation

    Psychiatry Research, Vol. 331

2023

  1. Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up

    International Journal of Neuropsychopharmacology, Vol. 26, Núm. 11, pp. 796-807

2022

  1. The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance

    The international journal of neuropsychopharmacology, Vol. 25, Núm. 8, pp. 666-677

  2. The effects of mango leaf extract during adolescence and adulthood in a rat model of schizophrenia

    Frontiers in Pharmacology, Vol. 13

  3. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study

    European Neuropsychopharmacology, Vol. 57, pp. 105-117

2021

  1. A Characterization of the Effects of Minocycline Treatment during Adolescence on Structural, Metabolic, and Oxidative Stress Parameters in a Maternal Immune Stimulation Model of Neurodevelopmental Brain Disorders

    International Journal of Neuropsychopharmacology, Vol. 24, Núm. 9, pp. 734-748

  2. Omega-3 fatty acids during adolescence prevent schizophrenia-related behavioural deficits: Neurophysiological evidences from the prenatal viral infection with PolyI:C

    European Neuropsychopharmacology, Vol. 46, pp. 14-27

2019

  1. Differences in the regulation of inflammatory pathways in adolescent- and adult-onset first-episode psychosis

    European Child and Adolescent Psychiatry, Vol. 28, Núm. 10, pp. 1395-1405

  2. Risperidone administered during adolescence induced metabolic, anatomical and inflammatory/oxidative changes in adult brain: A PET and MRI study in the maternal immune stimulation animal model

    European Neuropsychopharmacology, Vol. 29, Núm. 7, pp. 880-896

2016

  1. BDNF and NGF Signalling in Early Phases of Psychosis: Relationship with Inflammation and Response to Antipsychotics after 1 Year

    Schizophrenia Bulletin, Vol. 42, Núm. 1, pp. 142-151

2015

  1. Desarrollo profesional en investigación traslacional en neurociencias y salud mental: educación y formación dentro del Centro de Investigación Biomédica en Red en Salud Mental

    Revista de Psiquiatria y Salud Mental, Vol. 8, Núm. 2, pp. 65-74

  2. Pro-/antiinflammatory dysregulation in early psychosis: Results from a 1-year follow-Up study

    International Journal of Neuropsychopharmacology, Vol. 18, Núm. 2, pp. 1-10

  3. Stress increases the negative effects of chronic pain on hippocampal neurogenesis

    Anesthesia and Analgesia, Vol. 121, Núm. 4, pp. 1078-1088

2014

  1. Early responses to deep brain stimulation in depression are modulated by anti-inflammatory drugs

    Molecular Psychiatry, Vol. 19, Núm. 5, pp. 607-614

2013

  1. Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia.

    Translational psychiatry, Vol. 3

2012

  1. Comparison of the antinociceptive effects of ibuprofen arginate and ibuprofen in rat models of inflammatory and neuropathic pain

    Life Sciences, Vol. 90, Núm. 1-2, pp. 13-20

  2. Depressive-like states heighten the aversion to painful stimuli in a rat model of comorbid chronic pain and depression

    Anesthesiology, Vol. 117, Núm. 3, pp. 613-625

2011

  1. Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression

    Journal of Neuroinflammation, Vol. 8